Physician profile
Jiang Cui
NPI 1447331152
$14,361.06
in general payments reported to CMS, 2019-2025
28 companies · $5,858 in 2025
The $5,858 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,215 · 2020: $207 · 2021: $254 · 2022: $462 · 2023: $1,580 · 2024: $3,787 · 2025: $5,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,066 · Food and Beverage: $4,259 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,066.24 |
| Food and Beverage | $4,258.50 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,439.57 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $3,497.39 | 2019-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Accent |
| Boston Scientific Corporation | $1,602.30 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $1,382.02 | 2023-2025 | Carto 3, Qdot Micro Catheter, Na |
| Medical Device Business Services, INC. | $1,002.26 | 2023-2024 | Carto 3 |
| Impulse Dynamics (USA) INC. | $335.20 | 2023-2025 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $318.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $292.35 | 2019-2025 | |
| Philips North America LLC | $287.30 | 2022-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.95 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $180.99 | 2019-2023 | Camzyos, Eliquis |
| Bardy Diagnostics, INC. | $157.00 | 2021-2022 | |
| Amarin Pharma, INC. | $119.27 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $67.29 | 2019-2020 | |
| Cvrx, INC. | $57.00 | 2025 | Barostim Neo System |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $51.98 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $50.14 | 2019-2020 | |
| Amgen INC. | $44.95 | 2019-2025 | Repatha |
| Sanofi-Aventis U.S. LLC | $43.36 | 2019 | |
| Merck Sharp & Dohme LLC | $33.68 | 2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $32.90 | 2019 | |
| Lundbeck LLC | $32.62 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $28.49 | 2022 | |
| Biotronik INC. | $16.17 | 2020 | |
| Baxter Healthcare | $15.82 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Atricure, INC. | $14.61 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.83 | 2019 | |
| Chiesi USA, INC. | $13.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jiang Cui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.